Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

JOHNSON & JOHNSON Director's Dealing 2017

Feb 16, 2017

29750_dirs_2017-02-16_4072b3be-293e-4635-941a-e4a924f513bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2017-02-13

Reporting Person: Pruden Gary J (Exec VP, WW Chair, Med Devices)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-02-13 Common Stock M 15532.0000 Acquired 63405.4236 Direct
2017-02-13 Common Stock A 6197.0000 $0.0000 Acquired 69602.4236 Direct
2017-02-13 Common Stock F 9673.0000 $115.6700 Disposed 59929.4236 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2017-02-13 Performance Share Units $ M 15532.0000 Disposed Common Stock (15532.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 96.0000 Indirect

Footnotes

F1: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board.

F2: Shares earned due to performance factor of 139.9% upon vesting of Performance Share Units and certification of performance results by the Board.

F3: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board.

F4: Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2017).